Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2023-10-27 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
2023年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "启迪药业集团股份公司2023 年第三季度报告" which translates to "Qidi Pharmaceutical Group Co., Ltd. 2023 Third Quarter Report." It contains detailed financial data including balance sheets, income statements, cash flow statements, and explanations of financial metrics for the third quarter of 2023. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for a period shorter than a full fiscal year. It also mentions that the report is unaudited, which is typical for interim or quarterly reports. There is no indication that this is an announcement of a report or a certification document. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-10-27 Chinese
董事会战略委员会实施细则（2023年修订）
Governance Information Classification · 95% confidence The document is titled as the 'Implementation Rules of the Board Strategic Committee' of a company. It details the composition, responsibilities, decision-making procedures, meeting rules, and other governance-related aspects of the Board's Strategic Committee. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no announcements of reports, or any other financial or operational disclosures. The content is focused on internal governance structure and committee rules, which aligns with governance information about the company's board and its committees. Therefore, the document fits best under the category of Governance Information (CGR). The document length is 2029 characters, which is relatively short but contains substantive governance content, not just an announcement or certification.
2023-10-27 Chinese
董事会审计委员会实施细则（2023年修订）
Governance Information Classification · 95% confidence The document is titled as the 'Board Audit Committee Implementation Rules' of a company, detailing the composition, responsibilities, decision procedures, and meeting rules of the audit committee. It is a governance document outlining internal rules and procedures related to audit oversight within the board structure. There are no financial statements, audit opinions, or financial results presented. The document is not an audit report itself, nor an annual or interim report. It is not an announcement or a certification. It fits best under Governance Information (CGR) as it details the company's internal governance practices related to the audit committee.
2023-10-27 Chinese
独立董事工作制度（2023年修订）
Governance Information Classification · 100% confidence The document is titled '独立董事工作制度' which translates to 'Independent Director Work System' and details the governance structure, qualifications, nomination, duties, and rights of independent directors within the company. It references relevant laws, regulations, and company bylaws, focusing on internal governance practices and the role of independent directors. There is no financial data, earnings information, or report publication announcement. The content is a governance-related policy document outlining internal rules and procedures for board members, specifically independent directors. Therefore, it fits the category of Governance Information (CGR).
2023-10-27 Chinese
董事会薪酬与考核委员会实施细则（2023年修订）
Governance Information Classification · 95% confidence The document is titled as the implementation rules for the Board of Directors' Remuneration and Assessment Committee of a company. It details the committee's composition, responsibilities, decision-making procedures, and meeting rules related to remuneration and performance assessment of directors and senior management. There is no financial data, no report of financial results, no announcement of voting results, no legal proceedings, no capital changes, or other regulatory filings. The content focuses on governance practices related to remuneration and assessment, which fits the definition of Governance Information (CGR). The document length is 2485 characters, which is not a brief announcement but a detailed governance policy document. Therefore, the appropriate classification is Governance Information (CGR).
2023-10-27 Chinese
关于公司办公地址搬迁的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement about the company's office address relocation. It contains no financial data, no mention of financial results, no regulatory filings, no voting results, no management changes, or other report types. It is a general corporate announcement informing investors about the change in office address. The document length is only 344 characters, indicating it is a brief notice. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous corporate announcements that do not fit other specific categories.
2023-09-19 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.